Cargando…

Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer

BACKGROUND: Bladder cancer is a significant healthcare problem in the United States of America with a high recurrence rate. Early detection of bladder cancer is essential for removing the tumor with preservation of the bladder, avoiding metastasis and hence improving prognosis and long-term survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Datta, Antara, Adelson, Martin E, Mogilevkin, Yakov, Mordechai, Eli, Sidi, Abraham A, Trama, Jason P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130704/ https://www.ncbi.nlm.nih.gov/pubmed/21663673 http://dx.doi.org/10.1186/1471-2407-11-234

Ejemplares similares

CIP2A protein expression in high-grade, high-stage bladder cancer
por: Huang, Lisa P, et al.
Publicado: (2012)

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018)

The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation
por: Sandén, Carl, et al.
Publicado: (2014)

The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress
por: Ganz, Magdalena, et al.
Publicado: (2019)

Detection of Candida species in vaginal samples in a clinical laboratory setting.
por: Trama, Jason P, et al.
Publicado: (2005)

High-Risk HPV Genotype Distribution According to Cervical Cytology and Age
por: Trama, Jason P, et al.
Publicado: (2022)

DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma
por: Lee, Kam-Fai, et al.
Publicado: (2019)

DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
por: Lin, Lijuan, et al.
Publicado: (2013)

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2017)

The SAF-box domain of chromatin protein DEK
por: Böhm, Friederike, et al.
Publicado: (2005)

Super-resolution microscopy reveals the nanoscale cluster architecture of the DEK protein cancer biomarker
por: Pierzynska-Mach, Agnieszka, et al.
Publicado: (2023)

A DEK domain-containing protein GhDEK2D mediated Gossypium hirsutum enhanced resistance to Verticillium dahliae
por: Zhou, Jinglong, et al.
Publicado: (2022)

DEK protein level is a biomarker of CD138(positive) normal and malignant plasma cells
por: Çalışkaner, Zihni Onur, et al.
Publicado: (2017)

Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review
por: Habiburrahman, Muhammad, et al.
Publicado: (2022)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer
por: Pease, Nicholas A., et al.
Publicado: (2015)

DEK is required for homologous recombination repair of DNA breaks
por: Smith, Eric A., et al.
Publicado: (2017)

Role of the DEK oncogene in the development of squamous cell carcinoma
por: Ishida, Kazuhisa, et al.
Publicado: (2020)

Urinary biomarkers of overactive bladder
por: Tian, Xiao-Jun, et al.
Publicado: (2019)

Antagonistic effects of HTLV-1 Tax oncoprotein on BRCA1 expression and function
por: Huleihel, Mahmoud, et al.
Publicado: (2014)

Biomarkers of gene expression: growth factors and oncoproteins.
por: Brandt-Rauf, P W
Publicado: (1997)

Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion
por: Zhou, Qian-Cheng, et al.
Publicado: (2018)

High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)

Characterization of Enlarged Kidneys and Their Potential for Inducing Diabetes in DEK Rats
por: Domon, Ayaka, et al.
Publicado: (2021)

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Species-Specific Analysis of Bacterial Vaginosis-Associated Bacteria
por: Osei Sekyere, John, et al.
Publicado: (2023)

The human DEK oncogene regulates DNA damage response signaling and repair
por: Kavanaugh, Gina M., et al.
Publicado: (2011)

Mechanisms Underlying Cancer Growth and Apoptosis by DEK Overexpression in Colorectal Cancer
por: Lin, Lijuan, et al.
Publicado: (2014)

Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma
por: Yu, Le, et al.
Publicado: (2016)

Prognostic role of DEK in human solid tumors: a meta-analysis
por: Liu, Gang, et al.
Publicado: (2017)

Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis
por: Zhao, Ting, et al.
Publicado: (2019)

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
por: Matrka, Marie C., et al.
Publicado: (2017)

DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
por: Yang, Mai-Qing, et al.
Publicado: (2021)

DEK modulates both expression and alternative splicing of cancer-related genes
por: Liu, Bin, et al.
Publicado: (2022)

DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma
por: Yi, Huochun, et al.
Publicado: (2019)

Current and Emerging Bladder Cancer Urinary Biomarkers
por: Parker, Justin, et al.
Publicado: (2011)

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2012)

DEK promotes HPV positive and negative head and neck cancer cell proliferation
por: Adams, Allie K., et al.
Publicado: (2014)

Protein DEK and DTA Aptamers: Insight Into the Interaction Mechanisms and the Computational Aptamer Design
por: Dai, Lijun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g84q6mqk1fh4dlv2mgj8c3jss9